- Report
- February 2021
- 360 Pages
United States
From €2311EUR$2,400USD£1,988GBP
Ziagen (abacavir) is an antiretroviral drug used in the treatment of HIV/AIDS. It is a nucleoside reverse transcriptase inhibitor (NRTI) that works by blocking the action of the enzyme reverse transcriptase, which is needed for the virus to replicate. Ziagen is usually prescribed in combination with other antiretroviral drugs to treat HIV infection. It is available in tablet and oral solution form.
Ziagen is used in combination with other antiretroviral drugs to treat HIV infection in adults and children. It is also used to reduce the risk of HIV transmission from mother to child during pregnancy and delivery. Ziagen is generally well tolerated, but can cause side effects such as nausea, vomiting, and headache.
The Ziagen market is highly competitive, with several companies offering generic versions of the drug. Companies such as Mylan, Teva Pharmaceuticals, and Cipla are among the leading manufacturers of generic Ziagen. Other companies such as Gilead Sciences, GlaxoSmithKline, and Bristol-Myers Squibb also offer branded versions of the drug. Show Less Read more